# Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

> **NCT07091682** · NA · RECRUITING · sponsor: **Biotronik AG** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis of Coronary Artery
- Myocardial Ischemia
- Ischemic Heart Disease
- Acute Coronary Syndromes
- Angina Pectoris

## Interventions

- **DEVICE:** Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold

## Key facts

- **NCT ID:** NCT07091682
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-18
- **Primary completion:** 2027-06
- **Final completion:** 2031-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091682, "Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07091682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*